Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Eribulin + SDX-7320 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Eribulin | Halaven | Antimicrotubule Agent 14 | ||
| SDX-7320 | SDX7320|SDX 7320|evexomostat | SDX-7320 is a polymer-drug conjugate of SDX-7539, an inhibitor of methionine aminopeptidase 2 (METAP2), that is attached to a polymer backbone through a cleavable linker, which potentially leads to inhibition of tumor growth (Cancer Res 2022;82(4 Suppl):Abstract nr P5-05-04). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05570253 | Phase II | Eribulin + SDX-7320 Eribulin | A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer | Recruiting | USA | 0 |